Interest Expense in USD of ADMA BIOLOGICS, INC. from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Adma Biologics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2011 to Q1 2024.
  • Adma Biologics, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.77M, a 38.4% decline year-over-year.
  • Adma Biologics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $22.7M, a 3.07% increase year-over-year.
  • Adma Biologics, Inc. annual Interest Expense for 2023 was $25M, a 29.8% increase from 2022.
  • Adma Biologics, Inc. annual Interest Expense for 2022 was $19.3M, a 47.7% increase from 2021.
  • Adma Biologics, Inc. annual Interest Expense for 2021 was $13.1M, a 8.94% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)

ADMA BIOLOGICS, INC. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $22.7M $3.77M -$2.35M -38.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $25M $6.22M +$479K +8.35% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $24.5M $6.4M +$817K +14.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $23.7M $6.3M +$1.73M +37.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $22M $6.12M +$2.73M +80.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $19.3M $5.74M +$2.42M +73% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $16.9M $5.58M +$2.28M +69.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $14.6M $4.57M +$1.33M +40.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $13.3M $3.39M +$193K +6.05% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $13.1M $3.32M +$206K +6.64% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $12.9M $3.3M +$207K +6.71% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $12.6M $3.25M +$179K +5.85% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $12.5M $3.2M +$479K +17.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $12M $3.11M +$379K +13.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $11.6M $3.09M +$442K +16.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $11.2M $3.07M +$995K +48% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $10.2M $2.72M +$1.18M +76.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $8.99M $2.73M +$1.29M +89.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $7.7M $2.65M +$1.25M +88.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.45M $2.07M +$713K +52.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $5.74M $1.54M +$217K +16.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $5.52M $1.44M +$196K +15.8% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-13
Q3 2018 $5.33M $1.4M +$620K +79.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $4.71M $1.36M +$717K +112% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $3.99M $1.32M +$705K +114% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $3.29M $1.24M +$614K +97.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 $2.67M $783K +$177K +29.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.5M $642K +$104K +19.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $2.39M $619K +$151K +32.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $2.24M $628K +$164K +35.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 $2.08M $606K +$157K +34.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $1.92M $538K +$84.6K +18.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $1.83M $467K -$8.6K -1.81% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $1.84M $464K +$82.7K +21.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-24
Q3 2015 $1.76M $449K +$114K +34% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $1.65M $453K +$111K +32.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $1.54M $476K +$249K +110% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $1.29M $381K +$214K +127% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 $1.07M $335K +$172K +106% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $900K $343K +$184K +116% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $716K $227K +$98.1K +76.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $618K $168K +$151K +920% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-09
Q3 2013 $467K $163K +$160K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $307K $159K +$156K +5027% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $151K $129K +$120K +1416% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $30.7K $16.4K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 $2.65K* Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $3.1K -$237K -98.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $8.49K -$308K -97.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q2 2011 $240K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $316K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15

ADMA BIOLOGICS, INC. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $25M +$5.75M +29.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $19.3M +$6.22M +47.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $13.1M +$1.07M +8.94% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $12M +$2.99M +33.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $8.99M +$3.47M +62.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $5.52M +$2.24M +68.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $3.29M +$1.05M +46.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $2.24M +$397K +21.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 $1.84M +$557K +43.3% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-24
2014 $1.29M +$668K +108% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
2013 $618K +$588K +1915% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-09
2012 $30.7K -$1.57M -98.1% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 $1.6M Jan 1, 2011 Dec 31, 2011 10-K 2013-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.